- Home
- FXNC vs GOSS Comparison
FXNC vs GOSS Comparison
Compare FXNC & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FXNC
- GOSS
- Stock Information
- Founded
- FXNC 1907
- GOSS 2015
- Country
- FXNC United States
- GOSS United States
- Employees
- FXNC N/A
- GOSS N/A
- Industry
- FXNC Major Banks
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- FXNC Finance
- GOSS Health Care
- Exchange
- FXNC Nasdaq
- GOSS Nasdaq
- Market Cap
- FXNC 175.2M
- GOSS 203.3M
- IPO Year
- FXNC N/A
- GOSS 2019
- Fundamental
- Price
- FXNC $19.58
- GOSS $1.22
- Analyst Decision
- FXNC Strong Buy
- GOSS Strong Buy
- Analyst Count
- FXNC 1
- GOSS 4
- Target Price
- FXNC $21.00
- GOSS $7.75
- AVG Volume (30 Days)
- FXNC 17.6K
- GOSS 1.5M
- Earning Date
- FXNC 04-30-2025
- GOSS 05-15-2025
- Dividend Yield
- FXNC 3.11%
- GOSS N/A
- EPS Growth
- FXNC N/A
- GOSS N/A
- EPS
- FXNC 0.70
- GOSS N/A
- Revenue
- FXNC $64,227,999.00
- GOSS $124,590,000.00
- Revenue This Year
- FXNC $57.36
- GOSS N/A
- Revenue Next Year
- FXNC $5.03
- GOSS $190.37
- P/E Ratio
- FXNC $28.39
- GOSS N/A
- Revenue Growth
- FXNC 31.73
- GOSS N/A
- 52 Week Low
- FXNC $14.75
- GOSS $0.50
- 52 Week High
- FXNC $26.97
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- FXNC 38.72
- GOSS 59.87
- Support Level
- FXNC $20.18
- GOSS $1.09
- Resistance Level
- FXNC $21.18
- GOSS $1.20
- Average True Range (ATR)
- FXNC 0.41
- GOSS 0.09
- MACD
- FXNC -0.09
- GOSS 0.00
- Stochastic Oscillator
- FXNC 0.00
- GOSS 92.50
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.